HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Transcriptional regulation of the beta-synuclein 5'-promoter metal response element by metal transcription factor-1.

Abstract
The progression of many human neurodegenerative disorders is associated with an accumulation of alpha-synuclein. Alpha-synuclein belongs to the homologous synuclein family, which includes beta-synuclein. It has been proposed that beta-synuclein may be a natural regulator of alpha-synuclein. Therefore controlling beta-synuclein expression may control the accumulation of alpha-synuclein and ultimately prevent disease progression. The regulation of synucleins is poorly understood. We investigated the transcriptional regulation of beta-synuclein, with the aim of identifying molecules that differentially control beta-synuclein expression levels. To investigate transcriptional regulation of beta-synuclein, we used reporter gene assays and bioinformatics. We identified a region -1.1/-0.6 kb upstream of the beta-synuclein translational start site to be a key regulatory region of beta-synuclein 5'-promoter activity in human dopaminergic cells (SH-SY5Y). Within this key promoter region we identified a metal response element pertaining to a putative Metal Transcription Factor-1 (MTF-1) binding site. We demonstrated that MTF-1 binds to this 5'-promoter region using EMSA analysis. Moreover, we showed that MTF-1 differentially regulates beta-synuclein promoter binding site, as well as beta-synuclein mRNA and protein expression. This effect of MTF-1 on expression was found to be specific to beta-synuclein when compared to alpha-synuclein. Understanding the regulation of synucleins and how they interact may point to molecular targets that could be manipulated for therapeutic benefit. In this study we showed that MTF-1 differentially controls the expression of beta-synuclein when compared to its homolog alpha-synuclein. This could potentially provide a novel targets or pathways for therapeutic intervention and/or treatment of synucleinopathies.
AuthorsPatrick C McHugh, Josephine A Wright, David R Brown
JournalPloS one (PLoS One) Vol. 6 Issue 2 Pg. e17354 (Feb 28 2011) ISSN: 1932-6203 [Electronic] United States
PMID21386983 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • 5' Untranslated Regions
  • DNA-Binding Proteins
  • Metals
  • Transcription Factors
  • beta-Synuclein
  • transcription factor MTF-1
Topics
  • 5' Untranslated Regions (genetics)
  • Binding Sites (genetics)
  • Cells, Cultured
  • DNA-Binding Proteins (metabolism, physiology)
  • Electrophoretic Mobility Shift Assay
  • Gene Expression Regulation (drug effects, genetics)
  • Humans
  • Metals (pharmacology)
  • Mutagenesis, Site-Directed
  • Promoter Regions, Genetic (drug effects)
  • Protein Binding (physiology)
  • Response Elements (drug effects)
  • Transcription Factors (metabolism, physiology)
  • Transcriptional Activation (drug effects)
  • beta-Synuclein (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: